Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised Patients

Recruiting

DaRTAlpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised Patients

Sponsor:

Alpha Tau Medical LTD.

Code:

NCT06615635

Conditions

Squamous Cell Carcinoma

Alpha Radiation

Immunocompromised

Carcinoma, Squamous

Skin Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

DaRT seeds

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-06-24. This information was provided to ClinicalTrials.gov by Alpha Tau Medical LTD. on 2026-06-16.